IBDEI0UM ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13634,0)
 ;;=R63.3^^83^815^59
 ;;^UTILITY(U,$J,358.3,13634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13634,1,3,0)
 ;;=3^Feeding Difficulty
 ;;^UTILITY(U,$J,358.3,13634,1,4,0)
 ;;=4^R63.3
 ;;^UTILITY(U,$J,358.3,13634,2)
 ;;=^5019541
 ;;^UTILITY(U,$J,358.3,13635,0)
 ;;=E87.8^^83^815^60
 ;;^UTILITY(U,$J,358.3,13635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13635,1,3,0)
 ;;=3^Fluid & Electrolyte Balance Disorder NEC
 ;;^UTILITY(U,$J,358.3,13635,1,4,0)
 ;;=4^E87.8
 ;;^UTILITY(U,$J,358.3,13635,2)
 ;;=^5003026
 ;;^UTILITY(U,$J,358.3,13636,0)
 ;;=E87.70^^83^815^61
 ;;^UTILITY(U,$J,358.3,13636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13636,1,3,0)
 ;;=3^Fluid Overload,Unspec
 ;;^UTILITY(U,$J,358.3,13636,1,4,0)
 ;;=4^E87.70
 ;;^UTILITY(U,$J,358.3,13636,2)
 ;;=^5003023
 ;;^UTILITY(U,$J,358.3,13637,0)
 ;;=R73.01^^83^815^75
 ;;^UTILITY(U,$J,358.3,13637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13637,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,13637,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,13637,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,13638,0)
 ;;=R73.02^^83^815^76
 ;;^UTILITY(U,$J,358.3,13638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13638,1,3,0)
 ;;=3^Impaired Oral Glucose Tolerance
 ;;^UTILITY(U,$J,358.3,13638,1,4,0)
 ;;=4^R73.02
 ;;^UTILITY(U,$J,358.3,13638,2)
 ;;=^5019562
 ;;^UTILITY(U,$J,358.3,13639,0)
 ;;=E83.119^^83^815^62
 ;;^UTILITY(U,$J,358.3,13639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13639,1,3,0)
 ;;=3^Hemochromatosis,Unspec
 ;;^UTILITY(U,$J,358.3,13639,1,4,0)
 ;;=4^E83.119
 ;;^UTILITY(U,$J,358.3,13639,2)
 ;;=^5002995
 ;;^UTILITY(U,$J,358.3,13640,0)
 ;;=E83.52^^83^815^63
 ;;^UTILITY(U,$J,358.3,13640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13640,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,13640,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,13640,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,13641,0)
 ;;=E11.65^^83^815^20
 ;;^UTILITY(U,$J,358.3,13641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13641,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,13641,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,13641,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,13642,0)
 ;;=R73.9^^83^815^64
 ;;^UTILITY(U,$J,358.3,13642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13642,1,3,0)
 ;;=3^Hyperglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,13642,1,4,0)
 ;;=4^R73.9
 ;;^UTILITY(U,$J,358.3,13642,2)
 ;;=^5019564
 ;;^UTILITY(U,$J,358.3,13643,0)
 ;;=E87.5^^83^815^66
 ;;^UTILITY(U,$J,358.3,13643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13643,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,13643,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,13643,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,13644,0)
 ;;=E83.41^^83^815^67
 ;;^UTILITY(U,$J,358.3,13644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13644,1,3,0)
 ;;=3^Hypermagnesemia
 ;;^UTILITY(U,$J,358.3,13644,1,4,0)
 ;;=4^E83.41
 ;;^UTILITY(U,$J,358.3,13644,2)
 ;;=^5003002
 ;;^UTILITY(U,$J,358.3,13645,0)
 ;;=E87.0^^83^815^68
 ;;^UTILITY(U,$J,358.3,13645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13645,1,3,0)
 ;;=3^Hyperosmolality/Hypernatremia
 ;;^UTILITY(U,$J,358.3,13645,1,4,0)
 ;;=4^E87.0
 ;;^UTILITY(U,$J,358.3,13645,2)
 ;;=^5003018
 ;;^UTILITY(U,$J,358.3,13646,0)
 ;;=E83.51^^83^815^70
 ;;^UTILITY(U,$J,358.3,13646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13646,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,13646,1,4,0)
 ;;=4^E83.51
